Pfizer has been forced to reduce staff numbers and implement billion-dollar cuts in its operating costs following the collapse in COVID-19 vaccine and treatment sales over the past 12 months. The pharmaceutical giant is set to cut costs by $1 billion this year and at least $2.5 billion in 2024 as its annual revenue has almost … Continue reading Pfizer Cuts Costs After Collapse In Vax Uptake.